A new 1,4-dihydropyridine-based L-/T-type calcium channel inhibitor, provides in- vivo and silico cardioprotective effects in doxorubicin toxicity in rats
2026Human & Experimental ToxicologyJournalOpen access
10.1177/09603271261446916Full text1 citations